Toshiba launches Asteion

Article

Toshiba America Medical Systems this month formally introduced Asteion, its latest line of subsecond CT systems. Cleared by the Food and Drug Administration last November (SCAN 11/25/98), Toshiba’s Asteion VR and Asteion VI scanners feature a

Toshiba America Medical Systems this month formally introduced Asteion, its latest line of subsecond CT systems. Cleared by the Food and Drug Administration last November (SCAN 11/25/98), Toshiba’s Asteion VR and Asteion VI scanners feature a 0.75-second rotation speed and solid-state detectors, with partial reconstruction times as short as half a second using Toshiba’s image processing algorithms.

The units come equipped with the Tustin, CA-based company’s HeliCool x-ray tubes, rated at 4 MHU, and include graphic user interfaces and high-speed power image processors from Silicon Graphics. The scanners support Toshiba’s Aspire Continuous Imaging real-time scanning protocol. In the future, the Asteion line may be upgraded to Toshiba’s multislice technology, which will augment possible applications to include advanced CT-angio and cardiac studies, according to Toshiba.

The Asteion line expands Toshiba’s product offerings, enabling the company to provide both subsecond and multislice scanning at new price points. With the introduction last September of its Aquilion unit, a 0.5-second scanner, Toshiba established a platform for a multislice option to be introduced later this year (SCAN 3/3/99 and 9/16/98). But the Asteion scanners could bridge the gap between conventional single-slice scanners and Aquilion: Although Toshiba did not release a price tag for Asteion, the scanner will likely sell for less than Aquilion.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.